Do you biopsy pts with diabetes? Are you looking for diabetic nephropathy or something else?
Check out the blog by @dra_miliflores and @drpriyajohn
📣Now with a "audio abstract" at the top. Listen in the car to see if you want to read more! #NephTwitter
https://t.co/hNhGv45a54
10/10
Final thoughts:
✈️🚉🚗 we made it to #ERA26, sorry we're a little late on the posts!
Renal biopsy in diabetics is still a gold standard to rule out NDKD and improve the survival in diabetic patients…
Up next, LBCT from #ERA26
Join us at https://t.co/E2khgfJt2u
#TenPostNephJC#NephTwitter#NephJC
1/10
How often do we miss non-diabetic kidney disease (NDKD)?
🚩NDKD are 1) active urine sediment, 2) sudden worsening RFT, 3) absence of retinopathy 4) systemic symptoms like rash
@Tiff_Caza
https://t.co/0H9Rydx60J
11/10
Up Next: Clinical and histologic predictors of non-diabetic kidney disease in patients with diabetes mellitus 🔬
https://t.co/PI1KItx22W
Join us at https://t.co/ngV6TNPKjh
This has been @drpriyajohn with 10 posts
#NephJC#TenPostNephJC#NephTwitter
1/10
Building on the landmark findings of the SBP Intervention Trial, this study shows that team-based HTN care can successfully translate into meaningful CV benefits for underserved, low-income communities, IMPACTS-BP
https://t.co/AcuZB0clgm
10/10
Final thoughts
The CV system definitely rejoices at a SBP ⬇️ of 15.5 mmHg
The real world application of SPRINT in a low-income setting is impressive.
Can this be maintained to show hard CV outcomes? ⏰Time will tell.